A PHARMACEUTICAL COMPOSITION CONTAINING 3-[5-(2-FLUORO-PHENYL)-[1,2,4]OXADIAZOL-3-YL]-BENZOIC ACID

摘要

This invention relates to an oral pharmaceutical composition comprising an effective amount of 3-[5-(2-fluoro-phenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid or a pharmaceutically acceptable salt, thereof, a suspending agent selected from refined polydextrose, a binding agent selected from mannitol, surfactant agents selected from polyethylene glycol 3350 and poloxamer 407 powder, a disintegrant selected from crospovidone, and other excipients selected from hydroxyethyl cellulose, vanilla flavor, magnesium stearate and colloidal silica; wherein the effective amount of 3-[5-(2-fluoro-phenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid or a pharmaceutically acceptable salt is determined according to patient weight.